US FDA takes key actions for bulk drugs used for compounding

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1713卷 / 1期

关键词：

D O I：

10.1007/s40278-018-49838-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：4 / 4

相关论文

共 50 条

[41] US FDA aims to improve the safety of opioids used in pain management
Breeze, Sophie
PAIN MANAGEMENT, 2012, 2 (05) : 429 - 429
[42] The US FDA has recommended that paroxetine ['Paxil'] not be used in children and adolescents
Reactions Weekly, 2003, 957 (1) : 2 - 2
[43] Analysis of US FDA-Approved Drugs Containing Sulfur Atoms
Scott, Kevin A.
Njardarson, Jon T.
TOPICS IN CURRENT CHEMISTRY, 2018, 376 (01)
[44] US FDA approve three new drugs for Type 2 diabetes
Bond, Theo
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (02) : 103 - 103
[45] Highlights on Fluorine-Containing Drugs Approved by US FDA in 2023
Ali, Saghir
Bolinger, Andrew A.
Zhou, Jia
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2024, 24 (10) : 843 - 849
[46] Analysis of US FDA-Approved Drugs Containing Sulfur Atoms
Kevin A. Scott
Jon T. Njardarson
Topics in Current Chemistry, 2018, 376
[47] US FDA approves three new drugs for Type 2 diabetes
Bond, Theo
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2013, 6 (02): : 101 - 101
[48] Global consequences of the US FDA's accelerated approval of cancer drugs
Akhade, Amol
Sirohi, Bhawna
Gyawali, Bishal
LANCET ONCOLOGY, 2022, 23 (02): : 201 - 203
[49] Prescription drugs commonly used by US children, adolescents
Reactions Weekly, 2018, 1718 (1) : 11 - 11
[50] Changes in US antidepressant and antipsychotic prescription patterns in the time period following FDA actions
Pamer, Carol
Kaplan, Sigal
Wu, Yu-Te
Hammad, Tarek A.
Mosholder, Andrew D.
Rochester, George
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S95 - S96

← 1 2 3 4 5 →